Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F1BRZ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,823
Award facts
- Contract value 100% obligated
- $21,822.86 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $21,822.86 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pen injectors (2 ml units), with performance completed by January 9, 2026. This is a firm fixed-price, non-set-aside contract with performance at the contractor's Conshohocken, Pennsylvania location. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $1 billion through December 2031, which serves as the primary vehicle for supplying pharmaceutical products and medical supplies to military healthcare systems globally.
Dupixent (dupilumab) is a biologic medication commonly used to treat moderate-to-severe atopic dermatitis, eosinophilic asthma, and other allergic conditions, supporting the Defense Health Agency's pharmaceutical supply requirements for military treatment facilities and beneficiaries. AmerisourceBergen Drug Corp, as the subsidiary of Cencora, Inc., demonstrates significant federal procurement capability through its competitive wins and maintains a critical role in the federal medical supply chain for defense healthcare operations.
Quick answers
Who was awarded contract SPE2DR26F1BRZ?
SPE2DR26F1BRZ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 8, 2026.
How much is contract SPE2DR26F1BRZ worth?
The government has obligated $21,823 on SPE2DR26F1BRZ.
Is contract SPE2DR26F1BRZ an order under another contract?
Yes. SPE2DR26F1BRZ is a delivery order under SPE2DR25D2012, an indefinite delivery contract.
Was contract SPE2DR26F1BRZ competed?
The extent of competition for SPE2DR26F1BRZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award